The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Twelve hospitals across India will be part of the network which will support the trial in India
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
Dr. Reddy’s largest manufacturing facility in Bachupally, Hyderabad, joins Global Lighthouse Network of the World Economic Forum
There is also a growing interest in whole generation sequencing (WGS)
Subscribe To Our Newsletter & Stay Updated
